Annual Shareholders Equity
-$28.64 M
-$15.03 M-110.37%
31 December 2023
Summary:
Rigel Pharmaceuticals annual stockholders equity is currently -$28.64 million, with the most recent change of -$15.03 million (-110.37%) on 31 December 2023. During the last 3 years, it has fallen by -$62.67 million (-184.18%). RIGL annual shareholders equity is now -109.91% below its all-time high of $289.10 million, reached on 31 December 2012.RIGL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$14.64 M
+$15.28 M+51.07%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly stockholders equity is currently -$14.64 million, with the most recent change of +$15.28 million (+51.07%) on 30 September 2024. Over the past year, it has increased by +$17.20 million (+54.02%). RIGL quarterly shareholders equity is now -105.06% below its all-time high of $289.10 million, reached on 31 December 2012.RIGL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -110.4% | +54.0% |
| 3 y3 years | -184.2% | -129.5% |
| 5 y5 years | -126.1% | -121.2% |
RIGL Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -184.2% | at low | -129.5% | +54.0% |
| 5 y | 5 years | -126.1% | at low | -118.6% | +54.0% |
| alltime | all time | -109.9% | at low | -105.1% | +54.0% |
Rigel Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$14.64 M(-51.1%) |
| June 2024 | - | -$29.91 M(-5.5%) |
| Mar 2024 | - | -$31.67 M(+10.6%) |
| Dec 2023 | -$28.64 M(+110.4%) | -$28.64 M(-10.0%) |
| Sept 2023 | - | -$31.83 M(+13.2%) |
| June 2023 | - | -$28.11 M(+15.9%) |
| Mar 2023 | - | -$24.26 M(+78.2%) |
| Dec 2022 | -$13.62 M(-144.8%) | -$13.62 M(-31.4%) |
| Sept 2022 | - | -$19.83 M(+439.4%) |
| June 2022 | - | -$3.68 M(-154.1%) |
| Mar 2022 | - | $6.80 M(-77.6%) |
| Dec 2021 | $30.37 M(-10.7%) | $30.37 M(-38.8%) |
| Sept 2021 | - | $49.67 M(-27.1%) |
| June 2021 | - | $68.11 M(-13.0%) |
| Mar 2021 | - | $78.30 M(+130.1%) |
| Dec 2020 | $34.03 M(-36.8%) | $34.03 M(-33.2%) |
| Sept 2020 | - | $50.95 M(-19.4%) |
| June 2020 | - | $63.21 M(-19.5%) |
| Mar 2020 | - | $78.50 M(+45.9%) |
| Dec 2019 | $53.81 M(-51.0%) | $53.81 M(-21.9%) |
| Sept 2019 | - | $68.91 M(-12.0%) |
| June 2019 | - | $78.29 M(-17.9%) |
| Mar 2019 | - | $95.31 M(-13.3%) |
| Dec 2018 | $109.88 M(+9.2%) | $109.88 M(+6.2%) |
| Sept 2018 | - | $103.47 M(-16.3%) |
| June 2018 | - | $123.57 M(+54.8%) |
| Mar 2018 | - | $79.81 M(-20.7%) |
| Dec 2017 | $100.65 M(+82.9%) | $100.65 M(+79.2%) |
| Sept 2017 | - | $56.17 M(-19.3%) |
| June 2017 | - | $69.61 M(-17.2%) |
| Mar 2017 | - | $84.08 M(+52.8%) |
| Dec 2016 | $55.03 M(-39.8%) | $55.03 M(-16.6%) |
| Sept 2016 | - | $65.94 M(-10.5%) |
| June 2016 | - | $73.72 M(-2.3%) |
| Mar 2016 | - | $75.45 M(-17.4%) |
| Dec 2015 | $91.38 M(-28.7%) | $91.38 M(-5.2%) |
| Sept 2015 | - | $96.41 M(-4.7%) |
| June 2015 | - | $101.15 M(-9.8%) |
| Mar 2015 | - | $112.15 M(-12.6%) |
| Dec 2014 | $128.25 M(-38.4%) | $128.25 M(-12.7%) |
| Sept 2014 | - | $146.85 M(-11.4%) |
| June 2014 | - | $165.73 M(-12.0%) |
| Mar 2014 | - | $188.33 M(-9.6%) |
| Dec 2013 | $208.25 M(-28.0%) | $208.25 M(-6.8%) |
| Sept 2013 | - | $223.40 M(-8.8%) |
| June 2013 | - | $245.05 M(-7.6%) |
| Mar 2013 | - | $265.31 M(-8.2%) |
| Dec 2012 | $289.10 M | $289.10 M(+65.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $174.80 M(-10.7%) |
| June 2012 | - | $195.75 M(-9.6%) |
| Mar 2012 | - | $216.58 M(-8.3%) |
| Dec 2011 | $236.15 M(+42.1%) | $236.15 M(-8.5%) |
| Sept 2011 | - | $257.96 M(-5.4%) |
| June 2011 | - | $272.69 M(+82.6%) |
| Mar 2011 | - | $149.31 M(-10.1%) |
| Dec 2010 | $166.13 M(+51.2%) | $166.13 M(+33.5%) |
| June 2010 | - | $124.43 M(+34.1%) |
| Mar 2010 | - | $92.78 M(-15.5%) |
| Dec 2009 | $109.87 M(+5.5%) | $109.87 M(-15.7%) |
| Sept 2009 | - | $130.31 M(+152.8%) |
| June 2009 | - | $51.55 M(-33.0%) |
| Mar 2009 | - | $76.97 M(-26.1%) |
| Dec 2008 | $104.17 M(+26.7%) | $104.17 M(-20.3%) |
| Sept 2008 | - | $130.74 M(-19.4%) |
| June 2008 | - | $162.21 M(-14.5%) |
| Mar 2008 | - | $189.61 M(+130.7%) |
| Dec 2007 | $82.18 M(-5.8%) | $82.18 M(-12.9%) |
| Sept 2007 | - | $94.32 M(-14.5%) |
| June 2007 | - | $110.26 M(+51.4%) |
| Mar 2007 | - | $72.83 M(-16.5%) |
| Dec 2006 | $87.23 M(-19.7%) | $87.23 M(-12.3%) |
| Sept 2006 | - | $99.43 M(-5.6%) |
| June 2006 | - | $105.29 M(+1.5%) |
| Mar 2006 | - | $103.78 M(-4.4%) |
| Dec 2005 | $108.59 M(+107.6%) | $108.59 M(+4.5%) |
| Sept 2005 | - | $103.88 M(+204.1%) |
| June 2005 | - | $34.16 M(-23.7%) |
| Mar 2005 | - | $44.79 M(-14.4%) |
| Dec 2004 | $52.30 M(+30.8%) | $52.30 M(-14.2%) |
| Sept 2004 | - | $60.97 M(-16.9%) |
| June 2004 | - | $73.36 M(-15.1%) |
| Mar 2004 | - | $86.42 M(+116.2%) |
| Dec 2003 | $39.97 M(+57.1%) | $39.97 M(-21.2%) |
| Sept 2003 | - | $50.74 M(-2.9%) |
| June 2003 | - | $52.25 M(+198.9%) |
| Mar 2003 | - | $17.48 M(-31.3%) |
| Dec 2002 | $25.44 M(-12.1%) | $25.44 M(-22.0%) |
| Sept 2002 | - | $32.62 M(-23.4%) |
| June 2002 | - | $42.57 M(-18.5%) |
| Mar 2002 | - | $52.23 M(+80.5%) |
| Dec 2001 | $28.94 M(-40.9%) | $28.94 M(-15.6%) |
| Sept 2001 | - | $34.31 M(-15.2%) |
| June 2001 | - | $40.46 M(-9.8%) |
| Mar 2001 | - | $44.85 M(-8.5%) |
| Dec 2000 | $49.01 M(+6382.8%) | $49.01 M |
| Dec 1999 | $756.00 K | - |
FAQ
- What is Rigel Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual shareholders equity year-on-year change?
- What is Rigel Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Rigel Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of RIGL is -$28.64 M
What is the all time high annual shareholders equity for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual stockholders equity is $289.10 M
What is Rigel Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, RIGL annual stockholders equity has changed by -$15.03 M (-110.37%)
What is Rigel Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of RIGL is -$14.64 M
What is the all time high quarterly shareholders equity for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly stockholders equity is $289.10 M
What is Rigel Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, RIGL quarterly stockholders equity has changed by +$17.20 M (+54.02%)